Phastar Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
399
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
1
- Investments
-
1
Phastar General Information
Description
Provider of biometrics and clinical data services intended to serve pharmaceutical, biotechnology and medical device companies. The company specializes in biostatistics, statistical programming, statistical consulting, clinical data management and clinical trial reporting, thereby helping clients manage, analyze and report clinical trial data.
Contact Information
Website
www.phastar.comCorporate Office
- Suite 2S, Block 11 Alderley Park
- Congleton Road
- Nether Alderley SK10 4TG
- England, United Kingdom
Corporate Office
- Suite 2S, Block 11 Alderley Park
- Congleton Road
- Nether Alderley SK10 4TG
- England, United Kingdom
Phastar Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Phastar Comparisons
Industry
Financing
Details
Phastar Competitors (26)
One of Phastar’s 26 competitors is Waife & Associates, a Private Equity-Backed company based in Needham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Waife & Associates | Private Equity-Backed | Needham, MA | ||||
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| Ergomed Group | Private Equity-Backed | Guildford, United Kingdom | ||||
| Atlant Clinical | Corporate Backed or Acquired | Moscow, Russia | ||||
| Quanticate | Corporation | Hitchin, United Kingdom |
Phastar Signals
Phastar Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Phastar Investments (1)
Phastar’s most recent deal was a Buyout/LBO with S-cubed. The deal was made on 06-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| S-cubed | 06-Jan-2023 | Buyout/LBO | BPO/Outsource Services |
Phastar Exits (1)
Phastar’s most recent exit was on 06-Jan-2023 from S-cubed. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| S-cubed | 06-Jan-2023 | Completed |
|
Phastar Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Phastar Germany | Berlin, Germany | 2020 |
Phastar FAQs
-
When was Phastar founded?
Phastar was founded in 2007.
-
Where is Phastar headquartered?
Phastar is headquartered in Nether Alderley, United Kingdom.
-
What is the size of Phastar?
Phastar has 399 total employees.
-
What industry is Phastar in?
Phastar’s primary industry is Consulting Services (B2B).
-
Is Phastar a private or public company?
Phastar is a Private company.
-
What is Phastar’s current revenue?
The current revenue for Phastar is .
-
Who are Phastar’s investors?
Charterhouse Capital Partners has invested in Phastar.
-
Who are Phastar’s competitors?
Waife & Associates, North American Science Associates, Ergomed Group, Atlant Clinical, and Quanticate are some of the 26 competitors of Phastar.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process